Longevity research has often focused on combatting one specific aspect of ageing, like regenerating the liver or the brain. But recently, there’s been a shift towards looking for the silver bullet for all age-related diseases.
Marc Bernegger, a former crypto entrepreneur, cofounded the longevity company builder Maximon in 2021. He and his partners ran a two-day longevity investor conference last month in Gstaad in the Swiss Alps. The agenda included both investments opportunities and an overview of scientific research, with speakers including the investor Christian Angermayer and Eric Verdin, CEO of the Buck Institute for Research on Aging.